[Under what conditions should we propose a prophylactic mastectomy for a woman at risk?].
Gauthier-Villars
M
M
Unité de génétique oncologique, Institut Curie, Paris.
Blandy
C
C
Stoppa-Lyonnet
D
D
D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D019398:Genes, BRCA1 / Q000235:genetics; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D008408:Mastectomy / Q000379:methods*; D009363:Neoplasm Proteins / Q000235:genetics; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011379:Prognosis; D016019:Survival Analysis; D014157:Transcription Factors / Q000235:genetics
D024682:BRCA2 Protein; D005819:Genetic Markers; D009363:Neoplasm Proteins; D014157:Transcription Factors
Pour quelles raisons pourrait-on conseiller une mastectomie prophylactique à une femme à risque?